bluebird bio (BLUE)

P/S ratio as of November 2024 (TTM): 1.38

According to bluebird bio 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.43. At the end of 2024 the company had a P/S ratio of 3.46.

P/S ratio history for bluebird bio from 2013 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	3.46	-61.68%
2023	9.02	-94.35%
2022	159
2021	N/A	-100%
2020	11.5	-89.47%
2019	109	9.31%
2018	99.5	-59.67%
2017	247	-34.03%
2016	374	122.22%
2015	168	44.22%
2014	117	368.84%
2013	24.9

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
BioMarin Pharmaceutical BMRN	4.58	231.85%	🇺🇸 USA
Acceleron Pharma XLRN	N/A	N/A	🇺🇸 USA
Sanofi SNY	2.40	74.10%	🇫🇷 France
Sangamo Therapeutics SGMO	46.0	3,231.45%	🇺🇸 USA
Merck MRK	3.99	189.30%	🇺🇸 USA
GlycoMimetics GLYC	> 1000	184,754.13%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for bluebird bio (BLUE)

P/S ratio as of November 2024 (TTM): 1.38